FDA Approves GlaxoSmithKline AIDS Drug Tivicay

On August 12, the U.S. Food and Drug Administration approved GlaxoSmithKline Plc's drug Tivicay to treat the most common strain of HIV.

http://www.edgeprovidence.com/index.php?ch=health_fitness&sc=&sc2=features&sc3=&id=148492